EUR 741.00 For Business Accounts Only

Rx/Reimbursement Adult Incontinence in Germany

Even though incontinence continued to become less of a taboo over the review period, many German consumers still refrained from approaching their doctors about it. The inert feeling of shame and embarrassment that is still associated with no longer being in full control of bodily functions has limited the volume sales growth of incontinence products in Germany. Rx/reimbursement adult incontinence products, in particular, have been impacted by the negative stigma that incontinence still has for m...

Euromonitor International's Rx/Reimbursement adult incontinence in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2013-2017, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2022 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.